Abstract

Renal cell carcinomas (RCCs) metastasize to the adrenal glands via various mechanisms, including lymphatic vessel arterial embolism and retrograde venous embolism. The rate of ipsilateral metastasis is 3–5% and the rate of contralateral metastasis is ~0.7%, however, synchronous bilateral adrenal metastases are extremely rare. Therefore, the optimal diagnosis and treatment strategy for this condition is yet to be thoroughly defined. In the present study, a 50-year-old male patient presented with right flank pain. Ultrasonography (US) revealed a right renal mass and bilateral adrenal metastases, and a computerized tomography (CT) scan determined the size of the lesions: An 86×83×66-mm mass in the lower pole of the right kidney, an 18×12×10-mm mass in the right adrenal gland, and a 69×51×53-mm mass in the left adrenal gland with central necrosis and peripheral contrast uptake. A US-guided biopsy was performed which determined a diagnosis of right RCC and bilateral synchronous adrenal metastasis. Immunohistochemical examination of the biopsy revealed clear cell carcinoma (Fuhrman grade, III). Consequently, right radical nephrectomy, right partial adrenalectomy (with frozen section examination) and left adrenalectomy were planned. The bilateral synchronous adrenal metastases posed a challenge in the diagnosis and treatment of the disease, as there is no standard approach in the literature for the treatment of such patients. However, metastasectomy was selected, as it appears to be the most effective treatment strategy for increasing the rate of cancer-specific survival. As an adrenal mass was present in the current patient, a hormonal examination was recommended and an adrenal-preserving minimally invasive surgical procedure using frozen section examination during surgery was particularly important to prevent the patient from developing adrenal insufficiency.

Highlights

  • Renal cell carcinomas (RCCs) account for 2‐3% of all types of cancer worldwide and the highest incidence rate is observed in developed countries

  • A routine ipsilateral adrenalectomy is not recommended in cases of radical nephrectomy [6], as there is no difference in the overall survival rate between undergoing surgery and not undergoing surgery

  • In a retrospective study by Kobayashi et al [8], no statistically significant difference was identified in terms of cancer‐specific survival (CSS) between patients that underwent ipsilateral simultaneous adrenalectomy and patients that underwent adrenal‐sparing radical nephrectomy due to RCC

Read more

Summary

Introduction

Renal cell carcinomas (RCCs) account for 2‐3% of all types of cancer worldwide and the highest incidence rate is observed in developed countries. In the majority of RCC metastasis cases, removal of the metastatic mass contributes to the rate of survival; bilateral adrenalectomy may expose the patient to novel endocrinological complications, such as the development of iatrogenic Addison's disease. Two metastatic masses, measuring 69x51x53 mm and 18x12x10 mm, were detected in the left (Fig. 3) and right adrenal gland (Fig. 2), respectively, with central necrosis and peripheral contrast uptake. The specimens obtained from the right kidney using the US‐guided biopsy technique demonstrated characteristics typical of clear cell RCC, and high magnification examination of the right radical nephrectomy, right partial adrenalectomy and left adrenalectomy specimens revealed tumor cells with an alveolar structure, clear cytoplasm and small nucleolus (hematoxylin and eosin staining; magnification, x200; Fig. 4). A diagnosis of bilateral adrenal metastasis from clear cell RCC was established

Discussion
11. Karam JA and Wood CG
Findings
18. Plawner J

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.